António Guterres,UN Secretary-General Studies show that number of...
Category:
Health
Latest
Pension-related concerns, healthcare among top queries of senior citizens on govt helpline
About 65 per cent of senior citizens are facing financial problems...
New wearable sensor can monitor glucose, body temp via human sweat
"Sweat is ideal for real-time, continuous and non-invasive...
Third wave of COVID ‘inevitable’: Government
“Phase three is inevitable given the higher levels of circulating virus, but it is not clear on what time-scale this phase three will occur.We should be prepared for new waves,” said K Vijay Raghavan, the principal scientific advisor to the Centre.
Khuntia panel submits report to centre on increasing country’s insurance penetration
Subhash Chandra Khuntia, chairman, IRDAI, revealed that a proposal to initiate pilot projects covering some states or districts prone to natural disasters like cyclone and flooding has been sent to the government and the National Disaster Management Authority(NDMA).
The idea is to cover all dwelling units in a vulnerable geographical area against natural catastrophes. The cost of coverage upto a limit can be funded by the Government and the owners can pay additional premium for higher coverage. Since dwelling unit insurance is very cheap, this is quite affordable and feasible and will save Government expenditure in terms of compensation to the affected after the incident,’..
Looking at the size of India in terms of population, geographical spread, diversity and low insurance penetration, there is tremendous scope to have more insurance companies. The market is far below the saturation point.
Scientists find dangerous chemical pollutants in disposable face masks
Aa full investigation is necessary to determine the quantities and potential impacts of these particles leaching into the environment, and the levels being inhaled by users during normal breathing. This is a significant concern, especially for health care professionals, key workers, and children who are required to wear masks for large proportions of the working or school day.”
WTO mulling intellectual property waivers for vaccines
The argument, part of a long-running debate about intellectual property protections, centers on lifting patents, copyrights, and protections for industrial design and confidential information to help expand the production and deployment of vaccines during supply shortages. The aim is to suspend the rules for several years, just long enough to beat down the pandemic.
The issue has become more pressing with a surge in cases in India, the world’s second-most populous country and a key producer of vaccines, including one for Covid-19 that relies on technology from Oxford University and British-Swedish pharmaceutical maker AstraZeneca.
SC asks Centre to inform about settlement of insurance claims of healthcare professionals
“We direct the Central Government to inform this Court as to how many claims are pending under the Scheme, and the timeline within which the Central Government expects to settle them,” the bench, also comprising L Nageswara Rao and S Ravindra Bhat, said in its order uploaded on late Saturday night.
COVID-19: India records 3,57,229 new cases in single day,tally crosses 2-crore mark
Registering a steady increase, the active cases have increased to 34,47,133 comprising 17 per cent of the total infections, while the national COVID-19 recovery rate was recorded at 81.91 per cent, the data updated at 8 am showed.
HC asks Centre why it should not face contempt for failing to supply oxygen
A bench of Justices Vipin Sanghi and Rekha Palli also rejected the Centre’s submission that Delhi was not entitled to 700 metric tonnes of medical oxygen in light of existing medical infrastructure.
“We see grim reality everyday of people not able to secure oxygen or ICU beds in hospitals which have reduced beds due to gas shortage, the high court said.
Pfizer lifts sales forecast for coronavirus vaccine to $26 billion
The raised goal assumes 1.6 billion doses of vaccine, which is co-developed with BioNTech SE, will be delivered in the year, with the two-shot vaccine emerging as the best-selling product for the U.S. drugmaker in the first quarter.
“Based on what we’ve seen, we believe that a durable demand for our COVID-19 vaccine – similar to that of the flu vaccines – is a likely outcome,” Chief Executive Albert Bourla said in his prepared remarks.
Maruti Suzuki cuts production as car sales fall due to Covid lockdown
The problem is on the “sales side because in several states there is a partial lockdown and there’s a curfew in some states and the dealers who sell the cars are having to close down,” Maruti Chairman R.C. Bhargava said in an interview with Bloomberg Television on Tuesday. “Half the sales outlets are closed at the moment.”India’s largest carmaker was producing at full capacity before it also decided to shut some plants in order to divert oxygen to hospitals last week.
COVID-19: India records 3,780 fresh fatalities, 3,82,315 cases in single day
Registering a steady increase, the active cases have increased to 34,87,229 comprising 16.87 per cent of the total infections, while the national COVID-19 recovery rate was recorded at 82.03 per cent, the data updated at 8 am showed.